QQ客服 官方微博 反馈留言

	Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China.
	Zhao, Jingping; Jiang, Kaida; Li, Qingwei; Zhang, Yanlei; Cheng, Yan; Lin, Ziyi; Xuan, Jianwei*
刊名	Journal of medical economics
	2019
卷号	22期号:5页码:439-446
关键词	I18 I19 antipsychotics cost-effectiveness olanzapine orally disintegrating schizophrenia
ISSN号	1369-6998
DOI	10.1080/13696998.2019.1580714
URL标识	查看原文
WOS记录号	WOS:000464563900004
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3328337
专题	中南大学
作者单位	[Zhao, Jingping] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Zhao, Jingping,Jiang, Kaida,Li, Qingwei,et al. Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China.[J]. Journal of medical economics,2019,22(5):439-446.
APA	Zhao, Jingping.,Jiang, Kaida.,Li, Qingwei.,Zhang, Yanlei.,Cheng, Yan.,...&Xuan, Jianwei*.(2019).Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China..Journal of medical economics,22(5),439-446.
MLA	Zhao, Jingping,et al."Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China.".Journal of medical economics 22.5(2019):439-446.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。